| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.22 | 6e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |